Metabolic Tumor Volume Predicts Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Loncastuximab Tesirine in the Lotis-2 Trial

Authors :: Juan Pablo Alderuccio
Russ A Kuker
Isildinha M Reis
Muthiah Nachiappan
Brad S. Kahl
Mehdi Hamadani
Weiyun Z. Ai
John Radford
Melhem Solh
Kirit M. Ardeshna
Brian T. Hess
Matthew A. Lunning
Pier Luigi Zinzani
Anastasios Stathis
Carmelo Carlo-Stella
Eric Yu
Paolo F Caimi
Deukwoo Kwon
Izidore S. Lossos
Fei Yang
Craig H. Moskowitz
Source :: Blood. 140:6650-6652
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools